Looking to publish in Cancer Gene Therapy? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Try Livewrite NowCancer Gene Therapy is a journal focused on gene and cellular therapy for cancer researchers and clinicians.
Looking to publish in Cancer Gene Therapy? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Try Livewrite NowSubmission Instructions
Cancer Gene Therapy accepts the following article types. Click on an article type to view submission instructions.
Article
Review Article
Brief Communication
Correspondence
Perspective
Recent Publications
The Tumor-suppressive role of CNTNAP2 in glioma: Dual regulation of the NDN-ERK axis and M2 macrophage polarization
Yu Wu, Weiwei Zou, Shiqi Xia, Ti Zhang, Fan Yao, Yangqin Li, Xiaoqian Liu, Qian Peng, Xiao-Liang Xing
TP53 mutation at codon 179 metabolically reprograms cancer cells to promote invasion
Debina Sarkar, Gaurav C. Gyanwali, Jaishree Patel, Polina Shevchuk, Aaron Jeffs, Adele G. Woolley, Selena Wang, Maryam Sardari, Apeksha Bhandarkar, Halima Siddiqui, Magdalena Ratajska, Makhdoom Sarwar, Srinivasaraghavan Kannan, Chandra S. Verma, Catherine J. Drummond, Cushla McKinney, Jisha Antony, Sally P. McCormick, Antony Braithwaite, Sunali Mehta
The paradox of miR-107 in oncology: dual roles as a tumor suppressor and oncomiR
Mamdouh A. Ragab, Nevine Fathy, Yasmin M. Attia, Eman A. Amer, Sally A. Fahim
GOT1 promotes endometrial cancer progression by regulating ferroptosis through the STAT3-GPX4 axis and attenuating medroxyprogesterone acetate sensitivity
Yiran Li, Yuting Shen, Wen Lu
Clinical landscape and development of universal CAR-T cell therapies
Jincai Zhou
Frequently asked questions
How long does it take to publish?
Submission to first editorial decision: 5 median days. Submission to acceptance: 138 median days.
Reformat to Cancer Gene Therapy using Livewrite PremiumIs a cover letter required?
A cover letter on institutional letterhead is required at first submission.
Reformat to Cancer Gene Therapy using Livewrite PremiumWhat are the publication costs?
Standard publication is behind a paywall. Gold open access is available with an APC of £2,990 / $4,290 / €3,490, plus VAT or local taxes where applicable.
Reformat to Cancer Gene Therapy using Livewrite Premium